Acadia Pharmaceuticals (ACAD) Asset Utilization Ratio (2011 - 2026)

Acadia Pharmaceuticals' Asset Utilization Ratio history runs 16 years deep, the most recent figure standing at 0.69 for Q1 2026.

• In Q1 2026, Asset Utilization Ratio fell 19.53% year-over-year to 0.69; the TTM figure through Mar 2026 stood at 0.69 (down 19.53% YoY), while the FY2025 annual figure was 0.78, down 21.27% from the prior year.
• Asset Utilization Ratio for Q1 2026 stood at 0.69, down from 0.74 in the prior quarter.
• The five-year high for Asset Utilization Ratio was 1.05 in Q4 2023, with the low at 0.69 in Q1 2026.
• The 5-year median for Asset Utilization Ratio is 0.86 (2025), against an average of 0.88.
• The sharpest annual moves came in 2022 and 2026: Asset Utilization Ratio surged 32.27% in 2022, then slipped 19.53% in 2026.
• Acadia Pharmaceuticals' Asset Utilization Ratio stood at 0.87 in 2022, then climbed by 21.01% to 1.05 in 2023, then fell by 15.85% to 0.88 in 2024, then decreased by 16.35% to 0.74 in 2025, then fell by 6.64% to 0.69 in 2026.
• Business Quant data shows ACAD's Asset Utilization Ratio at 0.69 in Q1 2026, 0.74 in Q4 2025, and 0.82 in Q3 2025.